Neuro Connect Active
Natural health product licensed in Canada
- Licence holder
- NeuroReset Inc.
- NPN or DIN-HM
- 80090474
- Status
- Active licence
- Licence date
- 6 February 2019
- Revision date
- Not provided
- Form
- Vaporisateur
- Route of administration
- Topique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Arnica montana Source : Fleur | 20 % |
| Cedrus atlantica Source : Bois | 2 % |
Non-medicinal ingredients
Eau purifiée, Acide citrique, Poly(sorbate) 20, Sel de mer
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Pulvérisateur | minimum: 3 days ; maximum: 4 days |
Uses authorised in Canada
Arnica - (Traditionally) used in Herbal Medicine to help relieve pain and/or inflammation in muscles and joints (e.g. sprains, bruises, joint pain). Cedarwood - Used in aromatherapy to relieve minor skin irritation/cuts/bruises/burns. Cedarwood - Used in aromatherapy to help relieve joint/muscle pain associated with sprain/strain/rheumatoid arthritis. Cedarwood- Used in aromatherapy as a nervine/calmative.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family. If you are pregnant or breastfeeding, do not use this product.
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Keep out of reach of children. If accidental ingestion occurs, seek urgent medical attention or contact a Poison Control Center. If you have epilepsy or asthma, consult a health care practitioner prior to use. Do not expose the applied area(s) to the sun for 24 to 48 hours after application.
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in which case, discontinue use. If you experience nausea, dizziness, headache or an allergic reaction, discontinue use.
Source
Official Health Canada record, licence 80090474
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.